Improving Health, Health Care and Quality of Life

News Releases

Apr 1, 2003

DaVita Inc. Schedules First Quarter 2003 Investor Conference Call
Feb 13, 2003

DaVita inc. Reports 4th Quarter and Year End 2002 Results
Feb 10, 2003

Webcast Alert: DaVita Inc. Announces Q4 2002 Earnings Conference Call Webcast
Jan 9, 2003

DaVita Inc. Schedules Fourth Quarter and Year-End 2002 Investor Conference Call
Dec 10, 2002

DaVita Appoints Gail S. Wick to National Nursing Leadership Post
Nov 15, 2002

DaVita Inc. Adopts Rights Plan
Nov 12, 2002

DaVita Announces Appointment of Lori S. Richardson Pelliccioni, Chief Compliance Officer
Nov 5, 2002

DaVita Inc. Reports 3rd Quarter 2002 Results
Oct 30, 2002

Webcast Alert: DaVita Inc. Announces Q3 2002 Earnings Conference Call and Strategy Presentation Webcast
Oct 15, 2002

DaVita Schedules Investor Meeting on November 6, 2002
Sep 23, 2002

DaVita Honored by AARP
Aug 1, 2002

DaVita Inc. Reports 2nd Quarter 2002 Results
Jul 25, 2002

Webcast Alert: DaVita Q2 2002 Earnings Conference Call
Jun 17, 2002

DaVita Announces ALJ Decision for Florida Laboratory
Jun 7, 2002

DaVita Announces Continuing Developments Concerning the Company's Florida Laboratory
Jun 6, 2002

DaVita Announces Final Results of Stock Tender Offer
May 30, 2002

DaVita Announces Preliminary Results of Stock Tender Offer
May 15, 2002

DaVita Inc. Revises and Extends Tender Offer for Its Common Shares
May 9, 2002

DaVita Inc. Reports 1st Quarter 2002 Results
May 8, 2002

DaVita Inc. Announces Receipt of OIG Subpoena
May 6, 2002

DaVita Invites You to Join Its First Quarter Conference Call on the Web
May 2, 2002

DaVita Inc. Announces Extension of Expiration Date of the Tender Offer for Its Common Shares
May 2, 2002

DaVita Announces Development Concerning the Company's Florida Laboratory
Apr 29, 2002

Amgen Raises EPOGEN Pricing
Apr 25, 2002

DaVita Announces Closing of Note Tender Offer
Apr 23, 2002

DaVita Revises Purchase Price in Tender Offer and Consent Solicitation for Its 9.25% Senior Subordinated Notes Due 2011
Apr 19, 2002

DaVita Revises Tender Offers and Announces Satisfaction of Financing Condition
Apr 16, 2002

DaVita Sets Purchase Price in Tender Offer and Consent Solicitation For Its 9.25% Senior Subordinated Notes Due 2011
Apr 5, 2002

DaVita Announces Receipt of Requisite Consents for its 9.25% Senior Subordinated Notes Due 2011
Apr 1, 2002

Frequently Asked Questions Regarding DaVita Inc.'s Tender Offer to Buy Up to 24 Million Shares of Its Common Stock
Mar 20, 2002

DaVita Inc. Commences Tender Offers to Buy up to 24,000,000 Shares of Its Common Stock and Its 9.25% Senior Subordinated Notes due 2011
Mar 14, 2002

DaVita Inc. Plans to Buy up to 25,000,000 Shares of Its Common Stock And Its 91/4% Senior Subordinated Notes Due 2011
Feb 27, 2002

Webcast Alert: DaVita Inc. Q4 2001 Earnings
Feb 26, 2002

DaVita Inc. Reports 4th Quarter 2001 Results
Feb 19, 2002

Webcast Alert: DaVita Inc. Q4 2001 Earnings
Dec 3, 2001

DaVita Inc. Announces Share Repurchase Program
Nov 5, 2001

DaVita Inc. Reports 3rd Quarter 2001 Results
Oct 24, 2001

DaVita Inc. Announces (NYSE: DVA) Q3 2001 Earnings Release
Oct 15, 2001

DaVita Announces Appointment of Elizabeth B. Kelly, Vice President
Aug 1, 2001

DaVita Inc. Reports 2nd Quarter 2001 Results
Jul 20, 2001

DaVita Inc. Extends Exchange Offer Expiration Date
Jun 25, 2001

DaVita Inc. Announces Exchange Offer for its 9 1/4% Senior Subordinated Notes Due 2011
Jun 20, 2001

Davita Announces Second Quarter Earnings Release
Jun 4, 2001

Nancy-Ann DeParle and William L. Roper Join DaVita Board of Directors
May 10, 2001

DaVita says price of Amgen's Epogen raised 3.9 pct
May 9, 2001

Amgen Raises EPOGEN Pricing
May 6, 2001

DaVita Inc. Reports 1st Quarter 2001 Results
Apr 11, 2001

DaVita Completes $225 Million Private Offering 9 1/4% Senior Subordinated Notes
Apr 6, 2001

DaVita Inc. Announces Date for Q1 Earnings Release
Feb 26, 2001

DaVita Inc. Reports 4th Quarter and 2000 Results
Feb 21, 2001

/C O R R E C T I O N -- Davita Inc. (NYSE: DVA)/
Feb 5, 2001

DaVita Inc. Announces Cooperation With Government Inquiry
Jan 29, 2001

DaVita Inc. Scheduled to Speak at U.S. Bancorp Piper Jaffray Conference January 30, 2001
Nov 8, 2000

DaVita Inc. Reports 3rd Quarter Results
Oct 23, 2000

DaVita Inc. Appoints Thomas Scully to Its Board of Directors
Oct 5, 2000

DaVita Inc. (NYSE: TRL) Updates Revenue and EBITDA Outlook
Oct 4, 2000

Total Renal Care Holdings, Inc. Announces Legal Name Change to DaVita Inc.
Oct 2, 2000

/C O R R E C T I O N -- Total Renal Care Holdings, Inc/
Oct 2, 2000

DaVita Inc. (Total Renal Care Holdings, Inc.(NYSE: TRL)) Q3 2000 Earnings
Aug 9, 2000

Total Renal Care Reports 2nd Quarter Results
Jul 25, 2000

Total Renal Care Announces Settlement of Securities Class Actions
Jul 17, 2000

Total Renal Care Announces Restructuring of Senior Credit Facilities
Jun 5, 2000

Total Renal Care Announces New Company Name
May 16, 2000

Total Renal Care Announces Executive Appointments
May 10, 2000

Total Renal Care Reports 1st Quarter Earnings
May 8, 2000

Total Renal Care Announces Further Determination by Medicare Carrier Relating to the Ongoing Florida Laboratory Payment Dispute
Feb 25, 2000

Amgen Raises EPOGEN Pricing
Feb 12, 2000

Total Renal Care Announces Appointment of Richard K. Whitney, Chief Financial Officer
Feb 4, 2000

Total Renal Care Files Appeal of Florida Carrier Lab Decision
Feb 1, 2000

Total Renal Care Announces Appointment of Douglas Vlchek, Vice President
Feb 1, 2000

Total Renal Care Announces Effectiveness of Form S-3 For 7% Convertible Subordinated Notes
Jan 25, 2000

Total Renal Care Announces Appointment Of David Barry as President and Chief Operating Officer
Jan 20, 2000

Total Renal Care Announces the Signing of Definitive Agreements for the Sale of Selected Non-Continental U.S. Operations
Jan 19, 2000

Total Renal Care Announces Estimated Fourth Quarter Charges
Jan 14, 2000

Total Renal Care Announces Appointment of Leanne Zumwalt, Vice President, Investor Relations
Jan 6, 2000

Total Renal Care Announces Appointment of William S. Schilling, Vice President, Human Resources
Dec 1, 1999

Total Renal Care Appoints Richard B. Fontaine and C. Raymond Larkin to Its Board Of Directors
Nov 10, 1999

Total Renal Care Reports 3rd Quarter and 9 Months Earnings
Oct 18, 1999

Kent J. Thiry Named Chairman and Chief Executive Officer of Total Renal Care, Inc
Aug 10, 1999

Total Renal Care Reports 2nd Quarter Earnings and Charges
Aug 5, 1999

Total Renal Care Names George DeHuff Interim Chief Executive Officer
Jul 19, 1999

Total Renal Care Expects to Report Lower Earnings and Incur Charges
Jul 19, 1999

Victor Chaltiel Announces Plan to Step Down as Chairman and Chief Executive Officer of Total Renal Care
May 11, 1999

Total Renal Care Reports Record Revenues and Net Income for First Quarter 1999
May 11, 1999

Total Renal Care Names George B. DeHuff III President and Chief Operating Officer
May 6, 1999

Total Renal Care Names Jonathan S. Wolin Vice President of Audit and Compliance
Apr 1, 1999

Total Renal Care Holdings, Inc. Announces Filing of Form 10-K
Mar 31, 1999

Total Renal Care, Inc. Names Gerry Curry Vice President, Quality Management
Mar 17, 1999

Total Renal Care, Inc. Names Andrea M. Benko Vice President of Corporate Development, Acquisitions and Mergers
Mar 16, 1999

Total Renal Care, Inc. Names John J. McDonough Vice President and Chief Accounting Officer
Mar 5, 1999

Total Renal Care Denies Allegations Asserted in Class Action Suits; Company Clarifies Published Reports on SEC Comment Letter
Mar 1, 1999

Richard Lester Appointed Vice President, Investor Relations at Total Renal Care
Feb 18, 1999

Total Renal Care Reports Net Revenues Up 50% and Net Income (Before an Unusual Item) Up 63% For Fourth Quarter 1998
Feb 16, 1999

Total Renal Care Files Complaint Against Blue Cross and Blue Shield of Florida and HCFA
Nov 19, 1998

Total Renal Care Holdings Inc. Completes $345 Million Private Offering of 7% Convertible Subordinated Notes Due 2009
Nov 3, 1998

Total Renal Care Reports Net Revenues Up 61% and Net Income Up 99% For Third Quarter 1998 Earnings Per Share at 35 cents, Up 94% From Same Year-ago Quarter

Show per page

Contact Investor Relations

For media inquiries, please contact:

Media Kit

Kate Stabrawa
2000 16th Street
Denver, CO 80202
(303) 876-7527